TRV-2026-1239Version 2 · Revised

Saved · see the current record

Why this version exists

Editorial pass: sharper headline; gain/problem restated as concrete outcomes.

The exact text we saved

This is the version exactly as it was saved, character for character. The SHA-256 hash below is a 64-character code worked out from that text. Run the same text through SHA-256 and you get the same code; change a single letter and the code comes out completely different. Each version also stores the previous version’s hash, which chains them together so no version can be swapped out quietly.

TRUVACE RECORD VERSION
record: TRV-2026-1239
version: 2
kind: revised
reason: Editorial pass: sharper headline; gain/problem restated as concrete outcomes.
timestamp: 2026-11-04T09:50:19.742328Z
status: published
lens: g_space
sector: health
headline: Enhancing diagnostic precision for BI-RADS 4a breast nodules: A multimodal AI model integrating ultrasound radiomics, hemodynamic signatures, and clinical profiles
dek: Background Breast Imaging Reporting and Data System (BI-RADS) 4a nodules represent a diagnostic dilemma, with a malignancy rate ranging from 2% to 10%. The majority of these nodules prove benign after biopsy, leading to unnecessary invasive procedures, patient anxiety, and healthcare costs. Current clinical practice lacks a reliable, noninvasive tool to accurately distinguish benign from malignant BI-RADS 4a lesions. Emerging evidence suggests that integrating multiparametric ultrasound data with clinical factor…
gain_title: On 90 held-out breast nodules, a model combining ultrasound, blood-flow and clinical data caught all malignant ones (100% sensitivity) with 86.1% specificity and an AUC of 0.95.
problem_title: (none)
trace_subject: (none)
gain_reading: On 90 held-out breast nodules, a model combining ultrasound, blood-flow and clinical data caught all malignant ones (100% sensitivity) with 86.1% specificity and an AUC of 0.95.
gain_evidence: shows significant potential as a clinical decision-support tool to reduce unnecessary biopsies without compromising sensitivity
problem_reading: (none)
problem_evidence: (none)
quick_read: Researchers developed and validated a multimodal AI model to resolve the diagnostic ambiguity of BI-RADS 4a breast nodules, which have a 2% to 10% malignancy rate and often lead to benign biopsy results. Using data from 350 pathologically confirmed nodules across three hospitals, the LightGBM model combined ultrasound radiomics, hemodynamic features, and clinical profiles, achieving an AUC of 0.95 on a temporally independent test set of 90 nodules as of the October 2026 publication.

The result matters because BI-RADS 4a management currently lacks a reliable noninvasive tool, contributing to unnecessary invasive procedures, patient anxiety, and costs. A tool that maintains 100% sensitivity while improving specificity could support clinical decision-making and safely reduce biopsies, though real-world impact, generalizability beyond the three study hospitals, and prospective clinical utility remain to be confirmed.
limitation: 
tag: Evidence-backed gain
key_points: Prospective multicenter study enrolled 350 pathologically confirmed BI-RADS 4a nodules from 331 patients in one tertiary hospital and two secondary hospitals. | Model was built with Light Gradient Boosting Machine after LASSO feature selection, using grayscale ultrasound radiomics, hemodynamic parameters, and clinical data. | Training set n=260 with nested cross-validation and hyperparameter tuning; evaluation on temporally independent test set n=90. | Test performance significantly superior to Logistic Regression, Support Vector Machine, and Random Forest baseline classifiers.
rundown: The study collected clinical data, grayscale ultrasound images, and hemodynamic parameters for each nodule and extracted radiomics features, then constructed a multimodal fusion model using LightGBM following LASSO regression for feature selection.

Interpretability was addressed with SHapley Additive exPlanations (SHAP), and the model was developed on 260 nodules and tested on 90 temporally independent nodules, reporting AUC 0.95 with 100% sensitivity and 86.1% specificity.
sources:
- peer_reviewed | Journal of Applied Clinical Medical Physics | https://doi.org/10.1002/acm2.70800 | 2026-10-01
prev: 1ef02cc104a7ca8b6531cc3c4cf2a011967b9331640c96d3119b11100e3e3685
SHA-256 hash
a488ad0efd7fdbeb83677737f3bc60dbfa3e91a1c0e3d5aa5edb558b9be04c24
Previous version’s hash
1ef02cc104a7ca8b6531cc3c4cf2a011967b9331640c96d3119b11100e3e3685
Check this record hasn’t been altered
How to check it yourself, without trusting this page

Download any version from /api/record/TRV-2026-1239 and hash its canonical field yourself, for example with shasum -a 256. You should get its content_hash. Each version’s text also ends with prev:and the hash of the version before it (version 1 points to 64 zeros). If anyone had changed a single character of any version after it was saved, those hashes wouldn’t line up.